{
  "@context": "aku-v2",
  "@type": "pharmacology",
  "@id": "vascular:pharmacology:pharm-003-dti",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-07T01:00:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "last_updated": "2026-01-07T01:00:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pharmacology",
    "type": "pharmacology",
    "difficulty": "advanced",
    "importance": "high",
    "aku_id": "PHARM-003",
    "keywords": [
      "direct thrombin inhibitor",
      "DTI",
      "argatroban",
      "bivalirudin",
      "dabigatran",
      "HIT"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "anticoagulation",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:pharmacology:pharm-003-dti is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pharmacology that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:pharmacology:pharm-003-dti helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:pharmacology:pharm-003-dti include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:pharmacology:pharm-003-dti."
    }
  },
  "clinical_features": {
    "mechanism": {
      "target": "Factor IIa (thrombin) - direct binding",
      "independence": "Does not require antithrombin (unlike heparin)",
      "HIT_safety": "Does not cross-react with HIT antibodies"
    },
    "agents": {
      "argatroban": {
        "route": "IV infusion",
        "half_life": "39-51 minutes",
        "metabolism": "Hepatic (CYP3A4)",
        "monitoring": "aPTT (goal 1.5-3x baseline)",
        "HIT_dosing": "2 mcg/kg/min (reduce to 0.5 mcg/kg/min in hepatic impairment)",
        "PCI_dosing": "350 mcg/kg bolus then 25 mcg/kg/min",
        "caution": "Falsely elevates INR - complicates warfarin bridging"
      },
      "bivalirudin": {
        "route": "IV infusion",
        "half_life": "25 minutes",
        "metabolism": "20% renal, 80% enzymatic (plasma proteases)",
        "monitoring": "ACT for procedures",
        "PCI_dosing": "0.75 mg/kg bolus then 1.75 mg/kg/hr",
        "advantages": "Short half-life, predictable offset, good for procedures"
      },
      "dabigatran": {
        "route": "Oral",
        "half_life": "12-17 hours",
        "metabolism": "80% renal",
        "dosing": "150 mg BID (110 mg BID if CrCl 30-50 or age >75)",
        "reversal": "Idarucizumab (Praxbind) - specific reversal agent",
        "indications": "Non-valvular AFib, VTE treatment/prevention"
      }
    },
    "indications": {
      "HIT": "Argatroban first-line (or bivalirudin)",
      "PCI": "Bivalirudin (especially if HIT history)",
      "cardiac_surgery": "Bivalirudin for CPB in HIT",
      "VTE": "Dabigatran for treatment and prevention"
    },
    "monitoring": {
      "argatroban": "aPTT q4h until stable; goal 1.5-3x baseline",
      "bivalirudin": "ACT for procedures; no routine monitoring otherwise",
      "dabigatran": "No routine monitoring; dilute thrombin time or ecarin clotting time if needed"
    },
    "reversal": {
      "argatroban": "No specific antidote; short half-life allows offset; consider PCC",
      "bivalirudin": "Very short half-life (25 min) - stop infusion; consider PCC",
      "dabigatran": "Idarucizumab (Praxbind) 5g IV - complete reversal within minutes"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Direct Thrombin Inhibitors"
    },
    "altLabel": [
      "DTI",
      "Argatroban",
      "Bivalirudin",
      "Dabigatran"
    ],
    "definition": {
      "@language": "en",
      "@value": "Anticoagulants that bind directly to thrombin independent of antithrombin, used for HIT and procedural anticoagulation, with varying metabolic pathways determining agent selection."
    },
    "notation": "PHARM-003"
  },
  "relationships": {
    "prerequisites": [
      "vascular:pharmacology:pharm-001-heparin"
    ],
    "enables": [],
    "skos:broader": [
      "vascular:pharmacology:anticoagulation"
    ],
    "skos:related": [
      "vascular:pharmacology:HIT",
      "vascular:pharmacology:DOACs"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). vascular:pharmacology:pharm-003-dti. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "hematology fellows",
      "interventional cardiologists"
    ],
    "estimated_time": "20min",
    "learning_objectives": [
      "Compare parenteral DTIs (argatroban, bivalirudin)",
      "Select appropriate DTI based on hepatic/renal function",
      "Apply DTIs in HIT management",
      "Understand dabigatran reversal with idarucizumab"
    ],
    "clinical_pearls": [
      "Argatroban = HEPATIC metabolism - use in renal failure, avoid in liver failure",
      "Bivalirudin = SHORT half-life (25 min) - ideal for procedures",
      "Argatroban falsely elevates INR - complicates warfarin transition",
      "Idarucizumab (Praxbind) completely reverses dabigatran - available for emergencies",
      "DTIs do NOT cross-react with HIT antibodies - safe in HIT",
      "Dabigatran 80% renal - adjust or avoid in CrCl <30"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "416587008",
      "description": "Direct thrombin inhibitor"
    },
    {
      "codingSystem": "RxNorm",
      "codeValue": "114934",
      "description": "Argatroban"
    }
  ]
}